Image

North America Hunter Syndrome Treatment Market – Industry Trends and Forecast to 2028

Pharmaceutical

Image

North America Hunter Syndrome Treatment Market – Industry Trends and Forecast to 2028

  • Pharmaceutical
  • Published Report
  • Aug 2021
  • North America
  • 350 Pages
  • No of Tables: 64
  • No of Figures: 24

North America Hunter Syndrome Treatment Market, BySeverity (Mild to Moderate, Moderate to Severe), Type (Enzyme Replacement Therapy (ERT), Stem Cell Transplant, Surgical Treatment, Others), Complications (Respiratory Disorders, Neurological Disorders, Gastrointestinal Disorders, Cardiovascular, Ophthalmic, Audiologic, Dental, Musculoskeletal, Others), End User (Hospitals, Clinics, Home Healthcare, Others), Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy, Others), Country (U.S., Canada, Mexico)  Industry Trends and Forecast to 2028        

North America Hunter Syndrome Treatment Market Market Analysis and Insights : North America Hunter Syndrome Treatment Market

North America hunter syndrome treatment market is expected to gain market growth in the forecast period of 2021 to 2028. Data Bridge Market Research analyses that the market is growing with a CAGR of 9.3% in the forecast period of 2021 to 2028 and is expected to reach USD 652.66 million by 2028. The increase in R&D investment by public and private companies and technological advancements are the major drivers which propelled the demand of the market in the forecast period.

Hunter syndrome is a rare, inherited genetic disorder caused by missing or malfunctioning of enzyme, iduronate-2-sulfatase. Due to which body doesn’t properly digest or break down sugar molecules in the body. When these molecules build up in organs and tissues over time, they can cause damage that affects physical and mental development and abilities. The disorder almost always occurs in boys. The condition is one type of a group of inherited metabolic disorders called mucopolysaccharidosis (MPS).

Hunter syndrome is a rare, inherited disorder in which the body does not properly digest (break down) sugar molecules in the body. When these molecules build up in organs and tissues over time, they can cause damage that affects physical and mental development and abilities.

Public awareness about the syndrome and treatment options, improving healthcare infrastructure and increasing investment by the government for the growth of the healthcare industry across the globe is likely to accelerate the growth of the North America hunter syndrome treatment market in the forecast period. On the other hand, favourable government initiatives and technological advancements will further bring immense opportunities for the growth of the hunter syndrome treatment market in the above mentioned forecast period. However, adverse effects related to the treatment, lack of etiology, and low prevalence rate are factors expected to restraint the market growth in the forecast period.

The hunter syndrome treatment market report provides details of market share, new developments, and product pipeline analysis, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, product approvals, strategic decisions, product launches, geographic expansions, and technological innovations in the market. To understand the analysis and the market scenario contact us for an analyst brief, our team will help you create a revenue impact solution to achieve your desired goal.

North America Hunter Syndrome Treatment Market North America Hunter Syndrome Treatment Market Scope and Market Size

Hunter syndrome treatment market is segmented on the basis of severity, types, complications, end user and distribution channel. The growth among segments helps you analyze niche pockets of growth and strategies to approach the market and determine your core application areas and the difference in your target markets. 

  • On the basis of severity, the North America hunter syndrome treatment market is segmented into mild to moderate and moderate to severe. In 2021, the moderate to severe segment is dominating the North America hunter syndrome treatment market due to growing R&D activities.
  • On the basis of type, the North America hunter syndrome treatment market is segmented into enzyme replacement therapy (ERT), stem cell transplant, surgical treatment and others. In 2021, enzyme replacement therapy (ERT) is dominating the North America hunter syndrome treatment market due to somatic improvement, such as reduction in the frequency of respiratory infections, among others.
  • On the basis of complications, the North America hunter syndrome treatment market is segmented into respiratory disorders, neurological disorders, gastrointestinal disorders, cardiovascular, ophthalmic, audiologic, dental, musculoskeletal, others. In 2021, the respiratory disorders segment is dominating the North America hunter syndrome treatment market due to increasing R & D capabilities predicted to improve patient outcomes.
  • On the basis of end user, the North America hunter syndrome treatment market is segmented into hospitals, clinics, home healthcare and others. In 2021, the hospitals segment is dominating the North America hunter syndrome treatment market due to increased patient satisfaction, coupled with cost reduction.
  • On the basis of distribution channel, the North America hunter syndrome treatment market is segmented into hospital pharmacy, retail pharmacy, online pharmacy and others. In 2021, hospital pharmacy segment is dominating the North America hunter syndrome treatment market due to greater input in prescribing decisions about drugs and administration.

Hunter Syndrome Treatment Market Country Level Analysis

The hunter syndrome treatment market is analyzed and market size information is provided on the basis of severity, types, complications, end user and distribution channel.

The countries covered in the hunter syndrome treatment market report are U.S., Canada and Mexico. 

Enzyme replacement therapy (ERT) segment in North America region is expected to grow with the highest growth rate in the forecast period of 2021 to 2028 because of rise in clinical trials and increasing innovative R&D investments.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as new sales, replacement sales, country demographics, regulatory acts and import-export tariffs are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of North America brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of sales channels are considered while providing forecast analysis of the country data.

The Increase in the Cases of Inherited Genetic Disorders among Population across the Globe and Favorable Government Initiatives are Boosting the Market Growth of Hunter Syndrome Treatment Products

Hunter syndrome treatment market also provides you with detailed market analysis for every country growth in hunter syndrome treatment products industry with drugs sales, impact of advancement, technology and changes in regulatory scenarios with their support for the hunter syndrome treatment market. The data is available for historic period 2010 to 2019.

Competitive Landscape and Hunter Syndrome Treatment Market Share Analysis

Hunter syndrome treatment market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, production sites and facilities, company strengths and weaknesses, product launch, product trials pipelines, product approvals, patents, product width and breath, application dominance, technology lifeline curve. The above data points provided are only related to the company’s focus related to hunter syndrome treatment market.

The major companies operating in the North America hunter syndrome treatment are Takeda Pharmaceutical Company Limited, Medtronic, Abbott, On-X Life Technologies (a subsidiary of CryoLife Inc.), BD, Johnson & Johnson Services, Inc., Medical Device Business Services Inc., Stryker, Homology Medicines, Inc., UCB S.A., Novartis AG, Inventiva, Pfizer Inc., JCR Pharmaceuticals Co., Ltd., Sangamo Therapeutics, AVROBIO Inc., REGENXBIO Inc., CANbridge Life Sciences Ltd., Denali Therapeutics, and Jasper Therapeutics, among others. 

Many product launch and agreement are also initiated by the companies’ worldwide which are also accelerating the hunter syndrome treatment market.

For instance,

  • In March 2021, Children’s National Hospital and Takeda Pharmaceutical Company Limited announced the creation of the Rare Disease Clinical Activity Protocols (Rare-CAP) program, which will establish a networked system for the development, dissemination and curation of protocols to help standardize the process of diagnosis and care for patients with rare diseases. This partnership underscores companies’ commitment in driving continuous innovation and personalized care for patients with rare diseases.
  • In January 2021, Green Cross Corp. announced the marketing and manufacturing approval for Hunterase ICV (intracerebroventricular) Injection 15 mg (generic name: idursulfase-beta (recombinant)) as a treatment for MPS II (Hunter syndrome). This has helped the company develop and commercialize the treatment to fulfill the unmet needs of rare disease patients.
  • In January 2021, Pfizer Inc. announced that during the second half of 2020, it invested a total of USD 120.00 million in four clinical-stage biotech companies as part of the Pfizer Breakthrough Growth Initiative (PBGI). Pfizer is investing a huge amount of around USD 500.00 million in various biotechnology companies. This investment will help the Pfizer to ensure the continuity of promising clinical development programs for future strategic interest. It had helped the company to expand its business by entering and innovating new products. 

Collaboration, product launch, business expansion, award and recognition, joint ventures and other strategies by the market player is enhancing the company market in the hunter syndrome treatment market which also provides the benefit for organization to improve their offering for hunter syndrome treatment drugs.


SKU-

LIST OF TABLES 

TABLE 1 NORTH AMERICA HUNTER SYNDROME TREATMENT MARKET, BY SEVERITY, 2019-2028 (USD MILLION)

TABLE 2 NORTH AMERICA MODERATE TO SEVERE IN HUNTER SYNDROME TREATMENT MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 3 NORTH AMERICA MILD TO MODERATE IN NORTH AMERICA HUNTER SYNDROME TREATMENT MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 4 NORTH AMERICA HUNTER SYNDROME TREATMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 5 NORTH AMERICA ENZYME REPLACEMENT THERAPY (ERT) IN HUNTER SYNDROME TREATMENT MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 6 NORTH AMERICA ENZYME REPLACEMENT THERAPY (ERT) IN HUNTER SYNDROME TREATMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 7 NORTH AMERICA STEM CELL TRANSPLANT IN HUNTER SYNDROME TREATMENT MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 8 NORTH AMERICA STEM CELL TRANSPLANT IN HUNTER SYNDROME TREATMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 9 NORTH AMERICA SURGICAL TREATMENT IN HUNTER SYNDROME TREATMENT MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 10 NORTH AMERICA SURGICAL TREATMENT IN HUNTER SYNDROME TREATMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 11 NORTH AMERICA OTHERS IN HUNTER SYNDROME TREATMENT MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 12 NORTH AMERICA HUNTER SYNDROME TREATMENT MARKET, BY COMPLICATIONS, 2019-2028 (USD MILLION)

TABLE 13 NORTH AMERICA RESPIRATORY DISORDERS IN HUNTER SYNDROME TREATMENT MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 14 NORTH AMERICA NEUROLOGICAL DISORDERS IN HUNTER SYNDROME TREATMENT MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 15 NORTH AMERICA CARDIOVASCULAR IN HUNTER SYNDROME TREATMENT MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 16 NORTH AMERICA MUSCULOSKELETAL IN HUNTER SYNDROME TREATMENT MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 17 NORTH AMERICA GASTROINTESTINAL DISORDERS IN HUNTER SYNDROME TREATMENT MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 18 NORTH AMERICA OPHTHALMIC IN HUNTER SYNDROME TREATMENT MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 19 NORTH AMERICA AUDIOLOGIC IN HUNTER SYNDROME TREATMENT MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 20 NORTH AMERICA DENTAL IN HUNTER SYNDROME TREATMENT MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 21 NORTH AMERICA OTHERS IN HUNTER SYNDROME TREATMENT MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 22 NORTH AMERICA HUNTER SYNDROME TREATMENT MARKET: BY END USER, 2020

TABLE 23 NORTH AMERICA HOSPITALS IN HUNTER SYNDROME TREATMENT MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 24 NORTH AMERICA CLINICS IN HUNTER SYNDROME TREATMENT MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 25 NORTH AMERICA HOME HEALTHCARE IN HUNTER SYNDROME TREATMENT MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 26 NORTH AMERICA OTHERS IN HUNTER SYNDROME TREATMENT MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 27 NORTH AMERICA HUNTER SYNDROME TREATMENT MARKET: BY DISTRIBUTION CHANNEL, 2020

TABLE 28 NORTH AMERICA HOSPITAL PHARMACY IN HUNTER SYNDROME TREATMENT MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 29 NORTH AMERICA RETAIL PHARMACY IN HUNTER SYNDROME MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 30 NORTH AMERICA ONLINE PHARMACY IN HUNTER SYNDROME TREATMENT MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 31 NORTH AMERICA OTHERS IN HUNTER SYNDROME TREATMENT MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 32 NORTH AMERICA HUNTER SYNDROME TREATMENT MARKET, BY COUNTRY, 2019-2028 (USD MILLION)

TABLE 33 NORTH AMERICA HUNTER SYNDROME TREATMENT MARKET, BY SEVERITY, 2019-2028 (USD MILLION)

TABLE 34 NORTH AMERICA HUNTER SYNDROME TREATMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 35 NORTH AMERICA ENZYME REPLACEMENT THERAPY (ERT) IN HUNTER SYNDROME TREATMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 36 NORTH AMERICA STEM CELL TRANSPLANT IN HUNTER SYNDROME TREATMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 37 NORTH AMERICA SURGICAL TREATMENT IN HUNTER SYNDROME TREATMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 38 NORTH AMERICA HUNTER SYNDROME TREATMENT MARKET, BY COMPLICATIONS, 2019-2028 (USD MILLION)

TABLE 39 NORTH AMERICA HUNTER SYNDROME TREATMENT MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 40 NORTH AMERICA HUNTER SYNDROME TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 41 U.S. HUNTER SYNDROME TREATMENT MARKET, BY SEVERITY, 2019-2028 (USD MILLION)

TABLE 42 U.S. HUNTER SYNDROME TREATMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 43 U.S. ENZYME REPLACEMENT THERAPY (ERT) IN HUNTER SYNDROME TREATMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 44 U.S. STEM CELL TRANSPLANT IN HUNTER SYNDROME TREATMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 45 U.S. SURGICAL TREATMENT IN HUNTER SYNDROME TREATMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 46 U.S. HUNTER SYNDROME TREATMENT MARKET, BY COMPLICATIONS, 2019-2028 (USD MILLION)

TABLE 47 U.S. HUNTER SYNDROME TREATMENT MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 48 U.S. HUNTER SYNDROME TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 49 CANADA HUNTER SYNDROME TREATMENT MARKET, BY SEVERITY, 2019-2028 (USD MILLION)

TABLE 50 CANADA HUNTER SYNDROME TREATMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 51 CANADA ENZYME REPLACEMENT THERAPY (ERT) IN HUNTER SYNDROME TREATMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 52 CANADA STEM CELL TRANSPLANT IN HUNTER SYNDROME TREATMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 53 CANADA SURGICAL TREATMENT IN HUNTER SYNDROME TREATMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 54 CANADA HUNTER SYNDROME TREATMENT MARKET, BY COMPLICATIONS, 2019-2028 (USD MILLION)

TABLE 55 CANADA HUNTER SYNDROME TREATMENT MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 56 CANADA HUNTER SYNDROME TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 57 MEXICO HUNTER SYNDROME TREATMENT MARKET, BY SEVERITY, 2019-2028 (USD MILLION)

TABLE 58 MEXICO HUNTER SYNDROME TREATMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 59 MEXICO ENZYME REPLACEMENT THERAPY (ERT) IN HUNTER SYNDROME TREATMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 60 MEXICO STEM CELL TRANSPLANT IN HUNTER SYNDROME TREATMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 61 MEXICO SURGICAL TREATMENT IN HUNTER SYNDROME TREATMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 62 MEXICO HUNTER SYNDROME TREATMENT MARKET, BY COMPLICATIONS, 2019-2028 (USD MILLION)

TABLE 63 MEXICO HUNTER SYNDROME TREATMENT MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 64 MEXICO HUNTER SYNDROME TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

 

Please fill in the below form for Infographics

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Research Methodology:

Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.

The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.

Please fill in the below form for Research Methodology

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Customization Available:

Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.

Please fill in the below form for Available Customization

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Get online access to the report on the World's First Market Intelligence Cloud

  • Interactive Data Analysis Dashboard
  • Company Analysis Dashboard for high growth potential opportunities
  • Research Analyst Access for customization & queries
  • Competitor Analysis with Interactive dashboard
  • Latest News, Updates & Trend analysis
  • Harness the Power of Benchmark Analysis for Comprehensive Competitor Tracking
Request for Demo
Free Sample Report

CHOOSE LICENCE TYPE

  • 4200.00
  • 3500.00
  • 2000.00
  • 5500.00
  • 7500.00

Why Choose Us

Industry Coverage

DBMR works across the globe in multiple industries which equip us with knowledge across verticals and provide our clients with insights not only from their industry but how other industries will impact their ecosystem.

Regional Coverage

Coverage of Data Bridge is not restricted to developed or emerging economies. We work across the globe covering the largest array of countries where no other market research or business consulting firm has ever conducted research; creating growth opportunities for our clients in areas which are still unknown.

Technology Coverage

In today’s world, technology drives the market sentiment, so our vision is to provide our clients insights not only for developed technologies but upcoming and disrupting technological changes throughout the product lifecycle by enabling them with unforeseen opportunities in the market which will create disruption in their industry. This leads to innovation and our clients to come out as winners.

Goal Oriented Solutions

DBMR goal is to help our clients achieve their goals through our solutions; hence we formatively create the most appropriate solutions for our client needs, saving time and efforts for them to drive their grand strategies.

Unparallel Analyst Support

Our analysts take pride in our clients’ success. Unlike others, we believe in working along our clients to achieve their goals with 24 hours analyst support determining the correct needs and inspire innovation through service.

Banner

Client Testimonials